Top Anticancer Medicine Seeks Overseas Agents
You May Also Be Interested In:
A novel botanical and molecular targeted anticancer drug seeks agent companies in Asia, Middle East, Europe and South American regions for registration, importation and distribution.
Being on top of best selling anticancer formulations in the whole China, this medicine has been listed as "State Basic Drug" and "State Medical Insurance Drug". It is in emulsion form for intravenous infusion and has remarkable function in inhibiting and killing cancer cells while strengthening immune function to prevent metastasis and improve QOL, PPT & MST.
The drug has proven effect in treating cancers at site of lung, liver, esophagus, breast, pancreas, colon-rectum and prostate. It has been applied among over 600,000 patients in 2,300 hospitals in China and Russia with an annual turnover of over UD$40 million.
Experienced and professional foreign companies are welcome to contact us for product info and co-op details.